The Distribution of Histological Subtypes of Renal Tumors by Decade of Life Using the 2004 WHO Classification
Purpose
The 2004 World Health Organization histological classification of renal tumors reflects our understanding of the underlying molecular determinants of renal tumors. We reviewed all partial and radical nephrectomy specimens at Barnes-Jewish Hospital to determine if the distribution of renal tumor histological subtypes varies by decade of life using the new scheme.
Materials and Methods
A total of 1,043 consecutive cases of renal masses operated on for presumed malignancy from 1989 to 2003 were identified. All specimens were rereviewed by a single pathologist (MFS) and classified by the 2004 WHO scheme. In addition to decade of life and histological subtype, gender, tumor size and pathological tumor stage were analyzed.
Results
Analysis demonstrated an association between histological subtype and decade of life (p <0.001). The proportions of clear cell renal cell carcinoma (p = 0.008) and angiomyolipoma (p <0.001) decreased while the proportions of oncocytoma (p <0.001) and papillary renal cell carcinoma (p = 0.005) increased with increasing decade of life. The proportions of chromophobe (p = 0.181) and unclassified (p = 0.660) renal cell carcinoma did not change with increasing decade of life. In addition, younger patients were more likely to have larger tumors (p = 0.019) and metastatic disease at diagnosis (p = 0.017), while gender (p = 0.809) and tumor stage (p = 0.334) were not associated with increasing decade of life.
Conclusions
This study provides baseline histological subtypes by decade for the most common renal tumors using the 2004 WHO histological classification. Clinicians may consider using these trends along with imaging, history and physical examination to counsel patients before recommending treatment.
Key Words: kidney neoplasms, age groups, histology, nephrectomy, pathology
Abbreviations and Acronyms: AJCC, American Joint Committee on Cancer, AML, angiomyolipoma, CC, clear cell renal cell carcinoma, CDC, carcinoma of the collecting ducts, CHR, chromophobe renal cell carcinoma, MED, renal medullary carcinoma, MLC, multilocular cystic renal cell carcinoma, PAP, papillary renal cell carcinoma, RCC, renal cell carcinoma, UNCL, renal cell carcinoma unclassified
To access this article, please choose from the options below
Study received institutional board approval.Editor’s Note: This article is the first of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 794 and 795.
PII: S0022-5347(07)02578-5
doi:10.1016/j.juro.2007.09.076
© 2008 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Home Study CME Enrollment Form , 14 December 2007

